Catheter ablation of atrial tachyarrhythmias in patients with atrioventricular septal defect

Insights

Catheter ablation for atrial tachyarrhythmias in patients with atrioventricular septal defect (AVSD) shows excellent acute success. However, recurrences are common, especially with complex circuits in repeated procedures.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • Atrial tachyarrhythmias are prevalent in patients with atrioventricular septal defect (AVSD).
  • Limited data exist on catheter ablation outcomes for this specific patient population.

Purpose of the Study:

  • To elucidate the primary mechanisms of atrial tachyarrhythmias in AVSD patients.
  • To evaluate the efficacy and outcomes of catheter ablation in this cohort.

Main Methods:

  • An observational, multi-center cohort study included 56 AVSD patients undergoing catheter ablation for atrial tachyarrhythmias between 2004 and 2022.
  • Mechanisms of tachyarrhythmias were analyzed, focusing on re-entrant circuits.
  • Outcomes, including acute success and recurrence rates, were assessed during follow-up.

Main Results:

  • The most common mechanism was cavo-annular isthmus-dependent intra-atrial re-entrant tachycardia (IART) in 73.2% of patients.
  • Acute success was achieved in 96.4% with no reported complications.
  • Recurrence occurred in 39.3% of patients over a mean follow-up of 2.8 years, with 1-year freedom from recurrence at 77.5%.

Conclusions:

  • Cavo-annular isthmus circuits are predominant in AVSD patients with atrial tachyarrhythmias.
  • While acute ablation success is high, recurrences are frequent, necessitating further management.
  • Complex mechanisms, including bi-atrial and left-sided tachyarrhythmias, are more common in patients requiring repeat procedures.
Abstract

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
1.0K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
40
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
11
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
38
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16